Current issue

Back

Volume 34, issue 4

Review article

Adverse effects of venlafaxine therapy and risk factors for their occurrence

Justyna Suwała1, Marta Oleś1, Anna Wiela-Hojeńska1
1. Katedra i Zakład Farmakologii Klinicznej, Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu
Farmakoterapia w Psychiatrii i Neurologii 2018, 34 (4), 285–304
Date of publication: 11-12-2018
DOI: https://doi.org/10.33450/fpn.2019.01.003
Keywords: venlafaxine, adverse effects, risk factors

Pharmacovigilance is an important aspect of depression treatment, considering that 40–90% of patients experience side effects of antidepressant use. This paper discusses the issues of optimising the use of venlafaxine, including its pharmacodynamic and pharmacokinetic properties, indications, adverse effects and risk factors for their occurrence, such as co-morbidities or genetic polymorphisms and interactions with other drugs.

Address for correspondence:
mgr farm. Justyna Suwała
Uniwersytet Medyczny
im. Piastów Śląskich we Wrocławiu
email: justyna.suwala@student.umed.wroc.pl